Fluidigm Singapore launches Biomedical Product Development Centre

Singapore R&D center to develop life science instruments targeted for US$650 million market

05-Feb-2007

Fluidigm accelerates its R&D and manufacturing activities in Singapore, through the launch of its new Biomedical Product Development Center. This center, a core part of Fluidigm's worldwide R&D organization, will be responsible for the full development of a Fluidigm BioMark II series of instrumentation.

The center's initial research activities will support the development of instrumentation for the BioMark II system. The Singapore research group will undertake 100% of the R&D on a new biochip fluorescence reader and biochip loader, specially designed for high-throughput genotyping and protein expression applications. Fluidigm Singapore will also manufacture the BioMark II system.

Operations for the Biomedical Product Development Center will commence immediately, with its current R&D team of 5. Additional staff will be recruited from Singapore's pool of manufacturing and research expertise. The R&D center will also be supported by the local precision engineering companies, academic, biomedical and pharmaceuticals research institutions.

Other news from the department manufacturing

Most read news

More news from our other portals

Fighting cancer: latest developments and advances